Published in

Wiley, Diabetes, Obesity and Metabolism, 1(24), p. 154-159, 2021

DOI: 10.1111/dom.14540

Links

Tools

Export citation

Search in Google Scholar

Are novel glucose‐lowering agents' cardiorenal benefits generalizable to individuals of Black race? A meta‐trial sequential analysis to address disparities in cardiovascular and renal outcome trials enrolment

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO